Georgia Konstantinidou

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

International journal of molecular sciences

EMBO molecular medicine

Oncogene

Journal of experimental & clinical cancer research : CR

Universität Bern

Università degli Studi di Camerino (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universität Bern Aug 01 2016

Switzerland

SNSF Professor :: Institute of Pharmacology

Education History

Università degli Studi di Camerino Jan 01 2006 - Mar 09 2009

Italy

PHD :: Department of Bioscience and Biotechnology

Publications

Chiara Pozzato, Gonçalo Outeiro-Pinho, Mirco Galiè, Giorgio Ramadori, Georgia Konstantinidou
ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancer. EMBO molecular medicine (2024)
Maria Saliakoura, Georgia Konstantinidou
Lipid Metabolic Alterations in KRAS Mutant Tumors: Unmasking New Vulnerabilities for Cancer Therapy. International journal of molecular sciences 24 (2) (2023)
Maria Saliakoura, Georgia Konstantinidou
Lipid Metabolic Alterations in KRAS Mutant Tumors: Unmasking New Vulnerabilities for Cancer Therapy. International journal of molecular sciences 24 (2) (2023)
Maria Saliakoura, Georgia Konstantinidou
Lipid Metabolic Alterations in KRAS Mutant Tumors: Unmasking New Vulnerabilities for Cancer Therapy. International journal of molecular sciences 24 (2) (2023)
Maria Saliakoura, Georgia Konstantinidou
Lipid Metabolic Alterations in KRAS Mutant Tumors: Unmasking New Vulnerabilities for Cancer Therapy. International journal of molecular sciences 24 (2) (2023)
Maria Saliakoura, Matteo Rossi Sebastiano, Ioanna Nikdima, Chiara Pozzato, Georgia Konstantinidou
Restriction of extracellular lipids renders pancreatic cancer dependent on autophagy. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Zhang Yang, Shun-Qing Liang, Maria Saliakoura, Haitang Yang, Eric Vassella, Georgia Konstantinidou, Mario P Tschan, Balazs Hegedüs, Liang Zhao, Yanyun Gao, Duo Xu, Haibin Deng, Thomas M Marti, Gregor Jan Kocher, Wenxiang Wang, Ralph A Schmid, Ren-Wang Peng
Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS-mutant cancer. EMBO molecular medicine 13 (9) (2021)
Cédric Leroux, Georgia Konstantinidou
Targeted Therapies for Pancreatic Cancer: Overview of Current Treatments and New Opportunities for Personalized Oncology. Cancers 13 (4) (2021)
Maria Saliakoura, Inés Reynoso-Moreno, Chiara Pozzato, Matteo Rossi Sebastiano, Mirco Galié, Jürg Gertsch, Georgia Konstantinidou
The ACSL3-LPIAT1 signaling drives prostaglandin synthesis in non-small cell lung cancer. Oncogene 39 (14) (2020)
Maria Saliakoura, Matteo Rossi Sebastiano, Chiara Pozzato, Florian H Heidel, Tina M Schnöder, Spasenija Savic Prince, Lukas Bubendorf, Paolo Pinton, Ralph A Schmid, Johanna Baumgartner, Stefan Freigang, Sabina A Berezowska, Alessandro Rimessi, Georgia Konstantinidou
PLCγ1 suppression promotes the adaptation of KRAS-mutant lung adenocarcinomas to hypoxia. Nature cell biology 22 (11) (2020)
Matteo Rossi Sebastiano, Chiara Pozzato, Maria Saliakoura, Zhang Yang, Ren-Wang Peng, Mirco Galiè, Kevin Oberson, Hans-Uwe Simon, Evanthia Karamitopoulou, Georgia Konstantinidou
ACSL3-PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression. Science advances 6 (44) (2020)
Matteo Rossi Sebastiano, Georgia Konstantinidou
Targeting Long Chain Acyl-CoA Synthetases for Cancer Therapy. International journal of molecular sciences 20 (15) (2019)

Georgia Konstantinidou.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Georgia Konstantinidou